Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema.

Chakravarthy, Usha; Pearce, Ian; Banerjee, Sanjiv; Burton, Benjamin J L; Downey, Louise; Gale, Richard; Patel, Jignesh; Patra, Sudeshna; Sivaprasad, Sobha; Stevenson, Michael; Lupton, Susanne

Chakravarthy, Usha; Pearce, Ian; Banerjee, Sanjiv; Burton, Benjamin J L; Downey, Louise; Gale, Richard; Patel, Jignesh; Patra, Sudeshna; Sivaprasad, Sobha; Stevenson, Michael; Lupton, Susanne.

Afiliación

Chakravarthy U; Departmentof Ophthalmology, Queens University, Belfast, UK.
Pearce I; St Paul's Eye Unit, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Banerjee S; University Hospital of Wales, Cardiff, UK.
Burton BJL; Departmentof Ophthalmology, James Paget University Hospital, Great Yarmouth, UK.
Downey L; Department of Ophthalmology, Hull Royal Infirmary, Hull, UK.
Gale R; Departmentof Ophthalmology, The York Hospital UK, York, UK.
Patel J; Essex County Hospital, Colchester, UK.
Patra S; Whipps Cross University Hospital, London, UK.
Sivaprasad S; NIHR Moorfields Biomedical Research Centre, London, UK.
Stevenson M; Medical Education, Queens University of Belfast, Belfast, UK.
Lupton S; Departmentof Ophthalmology, Novartis Pharma UK, Frimley, UK.

BMJ Open Ophthalmol ; 4(1): e000226, 2019.

Article en En | MEDLINE | ID: mdl-31179389

Palabras clave

clinical trial; drugs; macula; retina; vision

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BMJ Open Ophthalmol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google